Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Amortizatization of Intangibles (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 10 years of Amortizatization of Intangibles data on record, last reported at $1.8 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 45.34% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $6.8 million, down 56.83%, while the annual FY2025 figure was $6.8 million, 56.83% down from the prior year.
  • Amortizatization of Intangibles reached $1.8 million in Q4 2025 per VRDN's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.7 million in Q1 2024 and bottomed at -$274000.0 in Q1 2022.
  • Average Amortizatization of Intangibles over 5 years is $1.7 million, with a median of $1.7 million recorded in 2025.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 468.25% in 2021, then soared 1415.54% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$250000.0 in 2021, then skyrocketed by 474.8% to $937000.0 in 2022, then skyrocketed by 227.32% to $3.1 million in 2023, then grew by 4.56% to $3.2 million in 2024, then tumbled by 45.34% to $1.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $1.8 million in Q4 2025, $1.1 million in Q3 2025, and $1.6 million in Q2 2025.